Safe Practices Recommendations for Healthcare
Professionals:
• At patient admission/presentation and
periodically throughout the patient’s stay at the
facility, assess the presence and use of therapies
containing interfering drugs (see previous page).
• Use only laboratory methods for monitoring
blood glucose levels in patients receiving
interfering drugs.
• If there are pre-print order sets for patients
receiving interfering drugs, include a prescription
to test blood glucose using only laboratory
methods.
• Establish facility protocols to verify point-of-care
(bedside) blood glucose results with laboratory
results for patients who are unresponsive or
unable to communicate.
5
To Next Page
Loading...
